FIELD: medicine.
SUBSTANCE: as a binding agent, the composition contains completely pregelatinised corn starch; as a filling agent, it contains microcrystalline cellulose; a disintegrating agent is sodium croscarmellose, and a lubricant is magnesium stearate. A completely pregelatinised corn starch/microcrystalline cellulose ratio makes 0.4. The composition can be presented in the form of tablets or Vivacoat-coated tablets. What is also presented is a method for producing the pharmaceutical composition. The composition is applicable for treating bacterial infections in mammals.
EFFECT: moxifloxacin tablets are lactose-free and characterised by adequate mechanical strength, hardness, stability and release properties.
4 cl, 5 tbl
Title | Year | Author | Number |
---|---|---|---|
ANTIBACTERIAL PHARMACEUTICAL COMPOSITION AND METHOD FOR PREPARING IT | 2013 |
|
RU2561037C2 |
PHARMACEUTICAL ANTI-DIABETIC COMPOSITION BASED ON SUBSTITUTED THIOPHENE CARBOXYLATE AND A METHOD FOR PRODUCTION THEREOF | 2018 |
|
RU2688235C1 |
PHARMACEUTICAL ANTIFUNGAL COMPOSITION BASED ON A CHLOROPHENYLBUTANEDIONE DERIVATIVE AND A METHOD FOR PRODUCTION THEREOF | 2019 |
|
RU2707286C1 |
COMBINED PREPARATION CONTAINING GEMIGLIPTIN AND METFORMIN AND METHOD FOR ITS PRODUCTION | 2013 |
|
RU2664422C2 |
TABLETS WITH IMPROVED INTAKE AND GOOD STORAGE STABILITY | 2013 |
|
RU2693005C2 |
TABLETS WITH IMPROVED INTAKE AND GOOD STORAGE STABILITY | 2013 |
|
RU2799052C1 |
STABLE PHARMACEUTICAL PREPARATION CONTAINING AMLODIPINE BENZYLATE AND ATENOLOL | 1998 |
|
RU2188636C2 |
PHARMACEUTICAL COMPOSITIONS OF MONTELUCAST AND LEVOCETIRISINE | 2013 |
|
RU2677649C2 |
COMPOSITION OF 3-OXY-6-METHYL-2-ETHYLPYRIDINE OR ITS PHARMACEUTICALLY ACCEPTABLE SALT IN TABLETTED FORM, METHOD FOR MAKING THEREOF, AND THERAPY | 2007 |
|
RU2384330C2 |
PHARMACEUTICAL COMPOSITION POSSESSING ANTIMICROBIAL ACTION, AND METHOD FOR PREPARING IT | 2012 |
|
RU2497501C1 |
Authors
Dates
2015-08-10—Published
2014-05-22—Filed